News

The issued patents include claims surrounding the composition and method of use for a biocompatible polyethylene glycol (PEG) coating and other stem cell encapsulation methods designed to enable

Under the collaboration, Omeros and The Parkinson’s Institute will conduct laboratory studies of one or more compounds that block Omeros’s proprietary target in a widely used and highly

The new drug application provides for the use of Abacavir sulfate 60mg tablets in combination with other antiretrovirals for use in pediatric patients for the treatment of HIV-1

Vertex intends to grant the underwriters an option to purchase up to an additional 1.05 million shares of its common stock. Goldman, Sachs & Co is acting as

This designation, following potential marketing approval in the future will give Vivendy seven years of market exclusivity and could facilitate the recovery of certain regulatory filing fees. Vivendy’s

Subsequently, Biovail, the Canadian pharmaceutical company, has acquired Prestwick. Under the terms of the agreement, Biovail and Ovation will jointly develop additional follow-on indications for Xenazine and related

With completion of the acquisition, full integration of the companies is well underway. All 30 employees of Lipomics will become part of Tethys. Steven Watkins, co-founder, president and

The original filing contained claims related to both diagnostics and therapeutics. During the reviewing process, the mixed nature of the claims resulted in a split (technically known as

The hepatitis C virus (HCV) treated patients were among end-stage renal disease patients enrolled in human safety studies being conducted at the Fortis Hospital, in Delhi, India. In